# Use of a Novel Fibrin Sealant in Total Knee Arthroplasty

> **NCT01656759** · PHASE2,PHASE3 · COMPLETED · sponsor: **Rush University Medical Center** · enrollment: 73 (actual)

## Conditions studied

- Osteoarthritis
- Intraoperative Bleeding

## Interventions

- **DRUG:** Evicel Fibrin Spray

## Key facts

- **NCT ID:** NCT01656759
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2014-12
- **Final completion:** 2015-08
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2016-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01656759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01656759, "Use of a Novel Fibrin Sealant in Total Knee Arthroplasty". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01656759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*